ADSL and infection: Unfortunately, the toxicity toward mammalian cells limits the use of most antibacterial surfaces, including those that are AMPs‐based.21, 24, 25, 26 Such toxicity prohibits cell adhesion that is critical to the healing process, hence increasing the risks of infection.27 To address this issue, AMPs are conjugated with hemocompatible/biocompatible polymers to reduce cytotoxicity.